Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy
Katrien Eger, Simone Hashimoto, Gert‐Jan Braunstahl, et al.
Respiratory Medicine (2020) Vol. 177, pp. 106287-106287
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

GEMA 5.3. Spanish Guideline on the Management of Asthma
Vicente Plaza, Isam Alobid, Cesáreo Álvarez Rodríguez, et al.
Open Respiratory Archives (2023) Vol. 5, Iss. 4, pp. 100277-100277
Open Access | Times Cited: 62
Asthma and COVID-19: a dangerous liaison?
Carlo Lombardi, Federica Gani, Alvise Berti, et al.
Asthma Research and Practice (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 46
Eosinophils—from cradle to grave
Miloš Jeseňák, Zuzana Diamant, Dagmar Simon, et al.
Allergy (2023) Vol. 78, Iss. 12, pp. 3077-3102
Open Access | Times Cited: 18
The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19
Yadong Gao, Ioana Agache, Mübeccel Akdiş, et al.
International Immunology (2021) Vol. 34, Iss. 4, pp. 177-188
Open Access | Times Cited: 39
How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group
Francesca Ferretti, Rosanna Cannatelli, Maurizio Benucci, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 37
Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology
Daniele Pala, Marco Pistis
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 36
Risk of serious COVID-19 outcomes among adults and children with moderate-to-severe asthma: a systematic review and meta-analysis
Bohee Lee, Grace Lewis, Eldad Agyei‐Manu, et al.
European Respiratory Review (2022) Vol. 31, Iss. 166, pp. 220066-220066
Open Access | Times Cited: 27
Viral Infection and Airway Epithelial Immunity in Asthma
So Ri Kim
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9914-9914
Open Access | Times Cited: 24
Emerging Evidence for Pleiotropism of Eosinophils
José M. Rodrigo‐Muñoz, Marta Gil‐Martínez, Beatriz Sastre, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7075-7075
Open Access | Times Cited: 32
Implications of preexisting asthma on COVID-19 pathogenesis
Rakhee K. Ramakrishnan, Saba Al Heialy, Qutayba Hamid
AJP Lung Cellular and Molecular Physiology (2021) Vol. 320, Iss. 5, pp. L880-L891
Open Access | Times Cited: 30
Severe Asthma and Active SARS-CoV-2 Infection: Insights into Biologics
Sara Manti, Michela Leotta, F. D’Amico, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 674-674
Open Access
SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics
Andriana Ι. Papaioannou, Evangelia Fouka, Νikolaos Tzanakis, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 10, pp. 2588-2595
Open Access | Times Cited: 17
Impact of the COVID-19 pandemic on the management of chronic noninfectious respiratory diseases
Angélica Tiotiu, Herberto Chong Neto, András Bikov, et al.
Expert Review of Respiratory Medicine (2021) Vol. 15, Iss. 8, pp. 1035-1048
Closed Access | Times Cited: 23
Impact of Anti-Type 2 Inflammation Biologic Therapy on COVID-19 Clinical Course and Outcome
Dimitri Poddighe, Elena Kovzel
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 6845-6853
Open Access | Times Cited: 23
Risk of COVID-19 and its complications in patients with atopic dermatitis undergoing dupilumab treatment—a population-based cohort study
Khalaf Kridin, Yochai Schonmann, A Solomon, et al.
Immunologic Research (2021) Vol. 70, Iss. 1, pp. 106-113
Open Access | Times Cited: 22
Recent advances in understanding the role of eosinophils
Gregory Constantine, Amy D. Klion
Faculty Reviews (2022) Vol. 11
Open Access | Times Cited: 14
Omalizumab may protect allergic patients against COVID-19: A systematic review
Daniele Giovanni Ghiglioni, Laura Cozzi, Riccardo Castagnoli, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 2, pp. 100741-100741
Open Access | Times Cited: 8
Safety of biologics in severe asthmatic patients with SARS‐CoV‐2 infection: A prospective study
Sara Manti, Alessandro Giallongo, Giulia Pecora, et al.
Pediatric Pulmonology (2023) Vol. 58, Iss. 4, pp. 1085-1091
Closed Access | Times Cited: 7
Dupilumab efficacy and safety in patients with moderate to severe asthma: A systematic review and meta-analysis
Mohamed Sayed Zaazouee, Asmaa Gomaa Alwarraqi, Yasmine Adel Mohammed, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
COVID-19 Clinical Features and Outcome in Italian Patients Treated with Biological Drugs Targeting Type 2 Inflammation
Giada Sambugaro, Elena Brambilla, Giulia Costanzo, et al.
Life (2024) Vol. 14, Iss. 3, pp. 378-378
Open Access | Times Cited: 2
Recent Updates in Experimental Research and Clinical Evaluation on Drugs for COVID-19 Treatment
Houwen Zou, Yuqi Yang, Huiqiang Dai, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 15
Patients with allergic asthma have lower risk of severe COVID-19 outcomes than patients with nonallergic asthma
Thomas Murphy, William W. Busse, Cécile Holweg, et al.
BMC Pulmonary Medicine (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Recomendaciones SEPAR sobre la vacuna COVID-19 en las enfermedades respiratorias
Felipe Villar Álvarez, Miguel Ángel Martínez‐García, David González Jiménez, et al.
Open Respiratory Archives (2021) Vol. 3, Iss. 2, pp. 100097-100097
Open Access | Times Cited: 14
Severe asthma in the era of COVID-19: A narrative review
João Gaspar Marques, Mafalda van Zeller, Pedro Martins, et al.
Pulmonology (2021) Vol. 28, Iss. 1, pp. 34-43
Open Access | Times Cited: 13
COVID-19 in patients with severe asthma using biological agents
Kurtuluş Aksu, Şenay Demir, Musa TOPEL, et al.
Tuberkuloz ve Toraks (2021) Vol. 69, Iss. 3, pp. 433-436
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top